$ALTH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALLOS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALLOS THERAPEUTICS INC. Get notifications about new insider transactions in ALLOS THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 ... 10 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.57 | 7,362 | 55,766 | 222,501 | 229.9 K to 222.5 K (-3.20 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.51 | 4,304 | 32,331 | 229,863 | 234.2 K to 229.9 K (-1.84 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 234,167 | 134.2 K to 234.2 K (+74.53 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Pharmaceutical ... | Option Exercise | A | 7.56 | 31,500 | 238,140 | 31,500 | |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Pharmaceutical ... | Sell | S | 7.51 | 1,468 | 11,025 | 23,002 | 24.5 K to 23 K (-6.00 %) |
| Feb 24 2010 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Pharmaceutical ... | Grant | A | 0.00 | 17,937 | 0 | 24,470 | 6.5 K to 24.5 K (+274.56 %) |
| Feb 10 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.00 | 32,580 | 228,086 | 134,167 | 166.7 K to 134.2 K (-19.54 %) |
| Jan 12 2010 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 7.00 | 65,160 | 456,120 | 166,747 | 231.9 K to 166.7 K (-28.10 %) |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | M | 2.42 | 45,428 | 109,909 | 0 | |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | M | 2.42 | 45,429 | 109,911 | 45,428 | |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | M | 2.42 | 45,429 | 109,911 | 90,857 | |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Sell | S | 7.30 | 45,428 | 331,738 | 474,870 | 520.3 K to 474.9 K (-8.73 %) |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Buy | M | 2.42 | 45,428 | 109,909 | 520,298 | 474.9 K to 520.3 K (+9.57 %) |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Sell | S | 7.11 | 45,429 | 322,918 | 474,870 | 520.3 K to 474.9 K (-8.73 %) |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Buy | M | 2.42 | 45,429 | 109,911 | 520,299 | 474.9 K to 520.3 K (+9.57 %) |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Sell | S | 6.76 | 45,429 | 307,114 | 474,870 | 520.3 K to 474.9 K (-8.73 %) |
| Jan 11 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Buy | M | 2.42 | 45,429 | 109,911 | 520,299 | 474.9 K to 520.3 K (+9.57 %) |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | M | 2.42 | 45,429 | 109,911 | 136,286 | |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | M | 2.42 | 45,428 | 109,909 | 181,715 | |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | M | 2.42 | 25,428 | 61,521 | 227,143 | |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Sell | S | 6.78 | 45,429 | 308,163 | 474,870 | 520.3 K to 474.9 K (-8.73 %) |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Buy | M | 2.42 | 45,429 | 109,911 | 520,299 | 474.9 K to 520.3 K (+9.57 %) |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Sell | S | 6.64 | 45,428 | 301,497 | 474,870 | 520.3 K to 474.9 K (-8.73 %) |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Buy | M | 2.42 | 45,428 | 109,909 | 520,298 | 474.9 K to 520.3 K (+9.57 %) |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Sell | S | 6.54 | 25,428 | 166,220 | 474,870 | 500.3 K to 474.9 K (-5.08 %) |
| Jan 06 2010 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Buy | M | 2.42 | 25,428 | 61,521 | 500,298 | 474.9 K to 500.3 K (+5.35 %) |
| Jan 04 2010 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Pharmaceutical ... | Buy | P | 5.59 | 211 | 1,180 | 6,533 | 6.3 K to 6.5 K (+3.34 %) |
| Oct 02 2009 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sr. VP, Chief Medic ... | Sell | D | 0.00 | 61,373 | 0 | 25,200 | 86.6 K to 25.2 K (-70.89 %) |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | M | 3.14 | 342,000 | 1,073,880 | 350,000 | |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 8.24 | 342,000 | 2,819,311 | 231,907 | 573.9 K to 231.9 K (-59.59 %) |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | M | 3.14 | 342,000 | 1,073,880 | 573,907 | 231.9 K to 573.9 K (+147.47 %) |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 85,400 | 267,302 | 100,000 | |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 8.13 | 85,400 | 694,302 | 88,873 | 174.3 K to 88.9 K (-49.00 %) |
| Aug 12 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 85,400 | 267,302 | 174,273 | 88.9 K to 174.3 K (+96.09 %) |
| Aug 07 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | M | 3.14 | 8,000 | 25,120 | 692,000 | |
| Aug 07 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 8.14 | 8,000 | 65,150 | 231,907 | 239.9 K to 231.9 K (-3.33 %) |
| Aug 07 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | M | 3.14 | 8,000 | 25,120 | 239,907 | 231.9 K to 239.9 K (+3.45 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 14,600 | 45,698 | 185,400 | |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 50,000 | 156,500 | 200,000 | |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 8.13 | 14,600 | 118,755 | 88,873 | 103.5 K to 88.9 K (-14.11 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 14,600 | 45,698 | 103,473 | 88.9 K to 103.5 K (+16.43 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 7.79 | 50,000 | 389,480 | 88,873 | 138.9 K to 88.9 K (-36.00 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 50,000 | 156,500 | 138,873 | 88.9 K to 138.9 K (+56.26 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | M | 2.70 | 25,000 | 67,500 | 75,000 | |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | M | 2.46 | 20,000 | 49,200 | 0 | |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | M | 2.00 | 5,000 | 10,000 | 0 | |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Sell | S | 8.00 | 50,000 | 400,000 | 20,060 | 70.1 K to 20.1 K (-71.37 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | M | 2.70 | 25,000 | 67,500 | 70,060 | 45.1 K to 70.1 K (+55.48 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | M | 2.46 | 20,000 | 49,200 | 45,060 | 25.1 K to 45.1 K (+79.81 %) |
| Aug 05 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | M | 2.00 | 5,000 | 10,000 | 25,060 | 20.1 K to 25.1 K (+24.93 %) |
| Jul 01 2009 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Pharmaceutical ... | Buy | P | 5.16 | 226 | 1,166 | 6,322 | 6.1 K to 6.3 K (+3.71 %) |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | CASEY MICHAEL D | Director | Option Exercise | A | 7.33 | 20,000 | 146,600 | 20,000 | |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | HEN STEWART | Director | Option Exercise | A | 7.33 | 20,000 | 146,600 | 20,000 | |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | A | 7.33 | 30,000 | 219,900 | 30,000 | |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | LATTS JEFFREY | Director | Option Exercise | A | 7.33 | 20,000 | 146,600 | 20,000 | |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | LYNCH TIMOTHY P | Director | Option Exercise | A | 7.33 | 20,000 | 146,600 | 20,000 | |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | LEFF JONATHAN S | Director | Option Exercise | A | 7.33 | 20,000 | 146,600 | 20,000 | |
| Jun 23 2009 | ALTH | ALLOS THERAPEUTICS ... | STOUT DAVID M | Director | Option Exercise | A | 7.33 | 20,000 | 146,600 | 20,000 | |
| Jun 17 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 8.16 | 13,500 | 110,124 | 88,873 | 102.4 K to 88.9 K (-13.19 %) |
| Jun 17 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 8.13 | 14,000 | 113,820 | 102,373 | 116.4 K to 102.4 K (-12.03 %) |
| Mar 27 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 39,500 | 123,635 | 250,000 | |
| Mar 27 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 6,900 | 21,597 | 289,500 | |
| Mar 27 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 7.37 | 39,500 | 291,206 | 116,373 | 155.9 K to 116.4 K (-25.34 %) |
| Mar 27 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 39,500 | 123,635 | 155,873 | 116.4 K to 155.9 K (+33.94 %) |
| Mar 27 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 7.13 | 6,900 | 49,209 | 116,373 | 123.3 K to 116.4 K (-5.60 %) |
| Mar 27 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 6,900 | 21,597 | 123,273 | 116.4 K to 123.3 K (+5.93 %) |
| Mar 20 2009 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sr. VP, Chief Medic ... | Sell | S | 6.63 | 6,200 | 41,079 | 86,573 | 92.8 K to 86.6 K (-6.68 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | M | 2.00 | 5,864 | 11,728 | 5,000 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | M | 2.00 | 69,136 | 138,272 | 10,864 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Sell | S | 7.00 | 5,864 | 41,048 | 20,060 | 25.9 K to 20.1 K (-22.62 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | M | 2.00 | 5,864 | 11,728 | 25,924 | 20.1 K to 25.9 K (+29.23 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Sell | S | 7.02 | 69,136 | 485,010 | 20,060 | 89.2 K to 20.1 K (-77.51 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | M | 2.00 | 69,136 | 138,272 | 89,196 | 20.1 K to 89.2 K (+344.65 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Option Exercise | M | 2.93 | 5,027 | 14,729 | 12,833 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Option Exercise | M | 2.93 | 9,140 | 26,780 | 17,860 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Option Exercise | M | 2.70 | 30,833 | 83,249 | 9,167 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Option Exercise | M | 2.46 | 15,000 | 36,900 | 0 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Option Exercise | M | 2.28 | 10,000 | 22,800 | 0 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Sell | S | 7.00 | 5,027 | 35,189 | 7,132 | 12.2 K to 7.1 K (-41.34 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Buy | M | 2.93 | 5,027 | 14,729 | 12,159 | 7.1 K to 12.2 K (+70.49 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Sell | S | 7.02 | 64,973 | 455,812 | 7,132 | 72.1 K to 7.1 K (-90.11 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Buy | M | 2.93 | 9,140 | 26,780 | 72,105 | 63 K to 72.1 K (+14.52 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Buy | M | 2.70 | 30,833 | 83,249 | 62,965 | 32.1 K to 63 K (+95.96 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Buy | M | 2.46 | 15,000 | 36,900 | 32,132 | 17.1 K to 32.1 K (+87.56 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | VP, Finance | Buy | M | 2.28 | 10,000 | 22,800 | 17,132 | 7.1 K to 17.1 K (+140.21 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 3,600 | 11,268 | 296,400 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | M | 3.13 | 50,000 | 156,500 | 300,000 | |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 7.13 | 3,600 | 25,674 | 116,373 | 120 K to 116.4 K (-3.00 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 3,600 | 11,268 | 119,973 | 116.4 K to 120 K (+3.09 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 7.13 | 50,000 | 356,500 | 116,373 | 166.4 K to 116.4 K (-30.05 %) |
| Mar 16 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | M | 3.13 | 50,000 | 156,500 | 166,373 | 116.4 K to 166.4 K (+42.97 %) |
| Mar 12 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | D | 6.54 | 34,235 | 224,000 | 231,907 | 266.1 K to 231.9 K (-12.86 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Manufacturing | Option Exercise | A | 6.40 | 35,000 | 224,000 | 35,000 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | BENNETT BRUCE K JR | VP, Manufacturing | Grant | A | 0.00 | 5,875 | 0 | 6,096 | 221 to 6.1 K (+2,658.37 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | A | 6.40 | 280,000 | 1,792,000 | 280,000 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Grant | A | 0.00 | 46,667 | 0 | 266,142 | 219.5 K to 266.1 K (+21.26 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sr. VP, Chief Medic ... | Option Exercise | A | 6.40 | 143,452 | 918,093 | 143,452 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sr. VP, Chief Medic ... | Grant | A | 0.00 | 23,873 | 0 | 92,773 | 68.9 K to 92.8 K (+34.65 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | A | 6.40 | 143,452 | 918,093 | 143,452 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Grant | A | 0.00 | 23,873 | 0 | 116,373 | 92.5 K to 116.4 K (+25.81 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Principal Financial ... | Option Exercise | A | 6.40 | 35,000 | 224,000 | 35,000 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Principal Financial ... | Grant | A | 0.00 | 5,875 | 0 | 7,132 | 1.3 K to 7.1 K (+467.38 %) |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | A | 6.40 | 90,496 | 579,174 | 90,496 | |
| Feb 25 2009 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Grant | A | 0.00 | 15,060 | 0 | 20,060 | 5 K to 20.1 K (+301.20 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.26 | 8 | 66 | 72,035 | 72 K to 72 K (-0.01 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.17 | 9,380 | 76,670 | 72,043 | 81.4 K to 72 K (-11.52 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.11 | 1,782 | 14,444 | 81,423 | 83.2 K to 81.4 K (-2.14 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.17 | 453 | 3,702 | 83,205 | 83.7 K to 83.2 K (-0.54 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.16 | 2,411 | 19,682 | 83,658 | 86.1 K to 83.7 K (-2.80 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.46 | 9,153 | 77,429 | 86,069 | 95.2 K to 86.1 K (-9.61 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.47 | 980 | 8,300 | 95,222 | 96.2 K to 95.2 K (-1.02 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 9.03 | 102 | 921 | 96,202 | 96.3 K to 96.2 K (-0.11 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.01 | 3,574 | 28,615 | 96,304 | 99.9 K to 96.3 K (-3.58 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.26 | 235 | 1,940 | 2,022,293 | 2 M to 2 M (-0.01 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.17 | 263,312 | 2,152,260 | 2,022,528 | 2.3 M to 2 M (-11.52 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.11 | 50,041 | 405,617 | 2,285,840 | 2.3 M to 2.3 M (-2.14 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.17 | 12,713 | 103,882 | 2,335,881 | 2.3 M to 2.3 M (-0.54 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.16 | 67,709 | 552,729 | 2,348,594 | 2.4 M to 2.3 M (-2.80 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.46 | 256,936 | 2,173,524 | 2,416,303 | 2.7 M to 2.4 M (-9.61 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.47 | 27,485 | 232,781 | 2,373,239 | 2.4 M to 2.4 M (-1.14 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 9.03 | 2,859 | 25,823 | 2,700,724 | 2.7 M to 2.7 M (-0.11 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 8.01 | 100,309 | 803,104 | 2,703,583 | 2.8 M to 2.7 M (-3.58 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.26 | 1 | 8 | 5,417 | 5.4 K to 5.4 K (-0.02 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.17 | 705 | 5,763 | 5,418 | 6.1 K to 5.4 K (-11.51 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.11 | 134 | 1,086 | 6,123 | 6.3 K to 6.1 K (-2.14 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.17 | 34 | 278 | 6,257 | 6.3 K to 6.3 K (-0.54 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.16 | 181 | 1,478 | 6,291 | 6.5 K to 6.3 K (-2.80 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.46 | 688 | 5,820 | 6,472 | 7.2 K to 6.5 K (-9.61 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.47 | 74 | 627 | 7,160 | 7.2 K to 7.2 K (-1.02 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 9.03 | 8 | 72 | 7,234 | 7.2 K to 7.2 K (-0.11 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | BAKER JULIAN | 10% Owner | Sell | S | 8.01 | 269 | 2,154 | 7,242 | 7.5 K to 7.2 K (-3.58 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.26 | 22 | 182 | 190,917 | 190.9 K to 190.9 K (-0.01 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 24,857 | 203,176 | 190,939 | 215.8 K to 190.9 K (-11.52 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.11 | 4,725 | 38,299 | 215,796 | 220.5 K to 215.8 K (-2.14 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 1,200 | 9,806 | 220,521 | 221.7 K to 220.5 K (-0.54 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.16 | 6,392 | 52,180 | 221,721 | 228.1 K to 221.7 K (-2.80 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.46 | 24,256 | 205,191 | 228,113 | 252.4 K to 228.1 K (-9.61 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.47 | 2,593 | 21,961 | 252,369 | 255 K to 252.4 K (-1.02 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 9.03 | 269 | 2,430 | 254,962 | 255.2 K to 255 K (-0.11 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.01 | 9,468 | 75,804 | 522,231 | 531.7 K to 522.2 K (-1.78 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.26 | 670 | 5,532 | 5,771,961 | 5.8 M to 5.8 M (-0.01 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.17 | 751,534 | 6,142,889 | 5,772,631 | 6.5 M to 5.8 M (-11.52 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.11 | 142,827 | 1,157,713 | 6,524,165 | 6.7 M to 6.5 M (-2.14 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.17 | 36,286 | 296,504 | 6,666,992 | 6.7 M to 6.7 M (-0.54 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.16 | 193,252 | 1,577,574 | 6,703,278 | 6.9 M to 6.7 M (-2.80 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.46 | 733,340 | 6,203,616 | 6,896,530 | 7.6 M to 6.9 M (-9.61 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.47 | 78,447 | 664,399 | 7,629,870 | 7.7 M to 7.6 M (-1.02 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 9.03 | 8,160 | 73,703 | 7,708,317 | 7.7 M to 7.7 M (-0.11 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 8.01 | 286,299 | 2,292,196 | 7,716,477 | 8 M to 7.7 M (-3.58 %) |
| Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 212 | 1,733 | 1,629 | 1.8 K to 1.6 K (-11.52 %) |